RESUMEN
Chimerism analysis has become an important tool to manage patients in the peri-transplant period of allogenic stem cell transplantation. During this period, cells of donor and host origin can coexist and increasing proportion of cells of host origin is considered as a recurrence of the underlying disease. We currently performed chimerism analysis on separate peripheral blood cell subsets, lymphocytes and granulocytes. To improve our isolation method, a new automated device from Stem Cell Technology Roboseptrade mark was tested and compared to our manual separation technique. The results obtained on T cell purification showed an improvement of the purity (98.42% with Robosep vs. 92.42% with the manual technique Rosettesep) and of the recovery (63.43% with Robosep and 38% with Rosettesep). The results were significantly improved on patient samples with less than 10% CD3 positive cells (purity: 90% vs. 44.44%; recovery: 73.79% vs. 43.98%). Granulocytes separation was based on CD15 expression. The results showed an improvement of the purity with Robosep (96.90% vs. 86.20% with the manual technique Polymorphprep) but the recovery was impaired (35.2% vs. 52.30%). Using a myeloid (CD66/CD33) cocktail, recovery was improved with the Robosep device (64.04% with the myeloid cocktail vs. 22.4% with the CD15 cocktail). Our data demonstrated that Robosep allowed a performant cell purification in the early period post-transplantation even for populations representing less than 10% of the peripheral blood cells.
Asunto(s)
Recuento de Células Sanguíneas/métodos , Separación Celular/métodos , Granulocitos/patología , Trasplante de Células Madre Mesenquimatosas , Células Madre Mesenquimatosas/patología , Robótica/métodos , Linfocitos T/patología , Separación Celular/instrumentación , Células Cultivadas , Humanos , Masculino , Reproducibilidad de los Resultados , Robótica/instrumentación , Sensibilidad y EspecificidadRESUMEN
Thrombocytopenia frequently occurs in laboratory practice. The present work illustrates, through the presentation of a case report of Wiskott-Aldrich syndrome, the difficulties encountered to identify and characterize thrombocytopenia. The clinicobiological validation of a low platelet count involves both the biologist, who must assume the validation of numeration while mentioning the morphological characteristics of the platelets and other blood cells, as well as the physician who has to interpret these data according to the clinical context.
Asunto(s)
Recuento de Plaquetas , Trombocitopenia/etiología , Síndrome de Wiskott-Aldrich/diagnóstico , Plaquetas/patología , Diagnóstico Diferencial , Humanos , Lactante , Masculino , Trombocitopenia/sangre , Trombocitopenia/patología , Síndrome de Wiskott-Aldrich/sangre , Síndrome de Wiskott-Aldrich/patologíaRESUMEN
A 48-year-old man, with persistent pyrexia, presented with thrombocytopenia and lymphocytosis. The peripheral blood smears showed atypical lymphocytes and a platelet satellitism phenomenon around atypical lymphocytes associated to lympho-agglutination. Platelet satellitism was exclusively observed with atypical lymphocytes in EDTA-treated blood and at room temperature. This phenomenon was not observed when adding normal plasma and could be reproduced several times. Flow cytometry analysis of the peripheral blood, cytological and histological studies revealed a marginal zone-B cell lymphoma. The mechanism underlying platelet satellitism is not fully understood, but is likely to involve an immunologic binding of EDTA-dependent antiplatelet autoantibodies directed against the platelets glycoprotein IIb/IIIa complex. The association between platelet satellitism and lymphoma could also involve a monoclonal Ig secreted by lymphoma cells.
Asunto(s)
Plaquetas/patología , Linfocitos/patología , Linfoma de Células B/patología , Humanos , Masculino , Persona de Mediana EdadRESUMEN
We report a case of hereditary elliptocytosis in an infant diagnosed a few months after the birth, in a context of regenerative normocytic normochromic anaemia. The investigations, including incubated osmotic fragility, erythrocytic enzymes study and haemoglobin electrophoresis, were not contributive. Only the persistence of elongated (or cigar-shaped) erythrocytes on blood smears was noted. Hereditary elliptocytosis was confirmed by specialized investigations (rheological study and erythrocytic membrane proteins electrophoresis). Investigations in the mother were realized and led to the discovery of a similar biological pattern. Hereditary elliptocytosis is a red blood cell membrane disorder due to the defect in cytoskeleton proteins (spectrin or 4.1), leading to the loss of deformability properties of erythrocytes. This disorder is considered as rare; however, its incidence is probably underestimated because most cases are pauci- or asymptomatic and the discovery is often fortuitous. The absence of detection of this defect by incubated osmotic fragility should not discard the hypothesis of erythrocytes membrane disorders. The persistent observation of elongated erythrocytes on blood smear must encourage the biologist to evocate a hereditary elliptocytosis.
Asunto(s)
Eliptocitosis Hereditaria/diagnóstico , Electroforesis de las Proteínas Sanguíneas , Diagnóstico Diferencial , Eliptocitosis Hereditaria/sangre , Deformación Eritrocítica , Membrana Eritrocítica , Femenino , Hemorreología , Humanos , Lactante , Proteínas de la Membrana/análisis , Fragilidad Osmótica , EspectrinaRESUMEN
We report a case of a de novo acute basophilic leukaemia, revealed by an infectious pneumopathy in a 73 year old man. The full blood count revealed an hyperleucocytosis associated with an unregenerative normocytic normochrom anaemia and a thrombocytopenia. The blood and bone marrow smears showed a mixture of undifferentiated blast cells and basophiloblasts (high nucleo-cytoplasmic ratio, coarse basophilic cytoplasmic granules), along with basophilic precursors and basophilic polymorphonuclears. All the blasts were MPO negative but positive for the toluidine blue metachromatic coloration, which is considered as consistent with basophilic lineage. Immunophenotypic studies showed myeloid blasts, without maturity marker, CD 117 negative and CD203 cytoplasmic positive, the latter known to be highly representative of the basophilic lineage. This very clear-cut phenotype, associated with the morphology of cells, were arguments to ascertain the basophilic lineage of the blasts without the need of electron microscopic study. Cytogenetic and RNA analysis revealed the presence of a Philadelphia chromosome and of a BCR-ABL transcript with the unusual junction e6a2. Thus, imatinib was added to the conventional chimiotherapy and the patient is currently in complete remission. This clinical prompted allows us to review the literature on acute basophilic leukaemia and to state on the different diagnostic criteria of this rare disorder.
Asunto(s)
Leucemia Basofílica Aguda/sangre , Leucemia Basofílica Aguda/diagnóstico , Anciano , Humanos , Inmunofenotipificación , Leucemia Basofílica Aguda/genética , Leucemia Basofílica Aguda/inmunología , Masculino , Cromosoma FiladelfiaRESUMEN
OP-9 cells are stromal cells derived from macrophage colony-stimulating factor (M-CSF)-deficient osteopetrotic mice. To evaluate the OP-9 capability to sustain long-term hematopoiesis, we reported the expansion of granulocyte colony-stimulating factor (G-CSF)-mobilized human peripheral blood (PB) CD34(+) cells in co-culture with murine OP-9 and MS-5 stromal cells, either transfected with various combinations of adenovectors (Ad) expressing c-kit ligand (KL) (either soluble or transmembrane form), thrombopoietin (TPO), flt-3/flk2 ligand (FL), and granulocyte-macrophage (GM)-CSF or with weekly addition of these cytokines. Expression of TPO as well as association of TPO, FL, and KL increased progenitor cell and week-6 cobblestone area forming cell (CAFC) production in all stromal co-cultures. Similar progenitor expansion was obtained by weekly addition of soluble cytokine. Five weeks of co-culture with OP9 and TPO, FL + KL resulted in the greatest expansion of progenitor cells and week-6 CAFC as measured by secondary assay on MS-5. In contrast to MS-5 and TPO or TPO + FL + KL cultures where hematopoiesis declined by week 4, progenitor as well as week-6 CAFC expansion continued for over 3 months in TPO + FL + KL OP9 cocultures. This was associated with decrease of CD14(+) macrophage production. The addition of human macrophage (M)-CSF or CD14(+) cells to the co-culture decrease progenitor and stem cell expansion; however, murine M-CSF to OP-9 co-cultures did not decrease progenitor expansion. High levels of stromal-derived factor-1 (SDF-1) production by MS-5 and low or absent production by OP-9 may account for stem cell adhesion and CAFC formation in the former cultures and the predominance of stem and progenitor cells in the nonadherent fraction in the latter cultures.
Asunto(s)
Antígenos CD34/metabolismo , Hematopoyesis/fisiología , Proteínas de la Membrana/metabolismo , Osteopetrosis , Factor de Células Madre/metabolismo , Células del Estroma/metabolismo , Trombopoyetina/metabolismo , Adenoviridae/genética , Adenoviridae/metabolismo , Adyuvantes Inmunológicos/metabolismo , Animales , Antígenos CD34/genética , Técnicas de Cultivo de Célula/métodos , Línea Celular , Quimiotaxis/fisiología , Técnicas de Cocultivo , Vectores Genéticos , Factor Estimulante de Colonias de Granulocitos y Macrófagos/genética , Factor Estimulante de Colonias de Granulocitos y Macrófagos/metabolismo , Humanos , Receptores de Lipopolisacáridos/genética , Receptores de Lipopolisacáridos/metabolismo , Factor Estimulante de Colonias de Macrófagos/metabolismo , Proteínas de la Membrana/genética , Ratones , Factor de Células Madre/genética , Células Madre/citología , Células Madre/metabolismo , Células del Estroma/citología , Trombopoyetina/genéticaRESUMEN
We report the case of an 2-year-old boy presenting an essential polycythemia since birth, with details of the diagnostic procedures used and clinical course. Pediatric cases are very rare, and a secondary acquired polycythemia should be first investigated. Most causes of primary childhood polycythemia remains unknown. Erythropoietin (EPO) level may help to separate diseases with high EPO (Chuvash, or yet unclassified), or with normal/low EPO (congenital with truncation of the EPO receptor, polycythemia vera-Vaquez disease-, or currently with unknown mechanism).
Asunto(s)
Eritropoyetina/sangre , Policitemia/diagnóstico , Biomarcadores/sangre , Preescolar , Hematócrito , Hemoglobinas/análisis , Humanos , Masculino , Oxígeno/sangre , Presión Parcial , Policitemia/sangreRESUMEN
Thrombocytopenia occurs frequently. We will illustrate, through the presentation of a clinical case, the difficulties encountered to identify and characterize thrombocytopenia. The clinicobiological validation of a low platelet count implies, at the same time, the biologist, who must assume the validation of numeration while mentioning the morphological characteristics of the platelets and other blood cells, as well as the clinician who must interpret these data according to the clinical context. Firstly, we will detail the basic rules to correctly ensure this validation. Secondly, we will see which are the arguments which that make it possible to direct the diagnosis towards an acquired or inherited thrombocytopenia. Lastly, we will approach the classification of inherited thrombocytopenias.
Asunto(s)
Trombocitopenia/clasificación , Trombocitopenia/diagnóstico , Femenino , Humanos , Lactante , Trombocitopenia/sangreRESUMEN
Epidural analgesia is often considered as risk of epidural haematoma in a patient with thrombocytopenia. In this observation, uncomplicated epidural analgesia was performed in a pregnant woman with hereditary macrothrombocytopenia. She received continuous epidural labour analgesia for a vaginal delivery with a platelet count at 63x10(9)/l but platelets with high mean platelet volume (20fL) and normal function. No neurological sequelae or excessive bleeding occurred.
Asunto(s)
Analgesia Epidural , Analgesia Obstétrica , Trombocitopenia/complicaciones , Adulto , Femenino , Hematoma Espinal Epidural/prevención & control , Humanos , Recuento de Plaquetas , Embarazo , Trombocitopenia/genéticaRESUMEN
INTRODUCTION: Automated haematology analysers may inaccurately determine platelet counts in several circumstances. Spuriously elevated automated platelet counts have been reported in some acute leukaemia (AL) cases because of fragmentation of circulating blast cells (pseudoplatelets). Haemorrhagic diathesis is a common manifestation of AL, which is often caused by severe thrombocytopenia. Therefore, overestimation of the actual platelet count in patients with AL can affect its clinical management. We aimed to detect the frequency of pseudoplatelets in patients with AL. METHODS: Complete blood cell counts were performed on 86 AL patients with three automated analysers (ADVIA 2120, Coulter LH 750 and Sysmex XE-2100D). Platelet counts were also performed by quantitative flow cytometry (QFC). The platelet counts of the automatic analysers were compared to the platelet counts by QFC. Blood smears were checked for the presence of pseudoplatelets. RESULTS: The automated analysers overestimated the platelet count due to the presence of pseudoplatelets in patients with AL. Pseudoplatelets were observed in the blood smears of 11 patients (13%). Three of these patients were near the prophylactic platelet transfusion threshold. CONCLUSION: Spurious increases in automated platelet counts by blast cell fragments are little known but frequent artefacts that should be ruled out by careful examination of peripheral blood smears.
Asunto(s)
Automatización de Laboratorios , Leucemia/sangre , Leucemia/patología , Células Neoplásicas Circulantes/patología , Recuento de Plaquetas/métodos , Recuento de Plaquetas/normas , Enfermedad Aguda , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Leucemia/diagnóstico , Masculino , Persona de Mediana Edad , Adulto JovenRESUMEN
INTRODUCTION: Chronic lymphocytic leukemia is usually diagnosed through the characteristic morphology/immunophenotype of the lymphocytes, but some CLL cases remain atypical resulting in diagnostic uncertainty. METHODS: Using flow cytometry analysis, we investigated the expression of CDs160/200 on B cells from 124 patients (82 CLL, 42 other B-cell neoplasms) and nine controls. CDs160/200 measurements were determined as a ratio of the mean fluorescence intensities of leukemic cells/controls and were considered positive when the ratios were ≥2 and 20, respectively. RESULTS: Sixty and 83% CLL expressed CDs160/200 as compared to 5% and 10% of other B-cell neoplasms, respectively. None of the controls showed CDs160/200 expressions. Combination of both markers was observed in 55% of CLL but only in 2% of other B-cell neoplasms, and absence of both markers occurred in 12% of CLL but in 86% of other B-cell neoplasms. CONCLUSION: CDs160/200 were associated with markers of the gold standard 'Matutes score' and could be useful markers to differentiate atypical CLL from other B-cell neoplasms in the absence of available biopsies or cytogenetics and molecular studies.
Asunto(s)
Antígenos CD/genética , Biomarcadores de Tumor/genética , Leucemia Linfocítica Crónica de Células B/diagnóstico , Receptores Inmunológicos/genética , Adulto , Anciano , Anciano de 80 o más Años , Antígenos CD/inmunología , Linfocitos B/inmunología , Linfocitos B/patología , Biomarcadores de Tumor/inmunología , Estudios de Casos y Controles , Diagnóstico Diferencial , Proteínas Ligadas a GPI/genética , Proteínas Ligadas a GPI/inmunología , Expresión Génica , Humanos , Leucemia de Células Pilosas/diagnóstico , Leucemia de Células Pilosas/genética , Leucemia de Células Pilosas/inmunología , Leucemia de Células Pilosas/patología , Leucemia Linfocítica Crónica de Células B/genética , Leucemia Linfocítica Crónica de Células B/inmunología , Leucemia Linfocítica Crónica de Células B/patología , Linfocitosis/diagnóstico , Linfocitosis/genética , Linfocitosis/inmunología , Linfocitosis/patología , Linfoma de Células B de la Zona Marginal/diagnóstico , Linfoma de Células B de la Zona Marginal/genética , Linfoma de Células B de la Zona Marginal/inmunología , Linfoma de Células B de la Zona Marginal/patología , Linfoma Folicular/diagnóstico , Linfoma Folicular/genética , Linfoma Folicular/inmunología , Linfoma Folicular/patología , Linfoma de Células del Manto/diagnóstico , Linfoma de Células del Manto/genética , Linfoma de Células del Manto/inmunología , Linfoma de Células del Manto/patología , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Curva ROC , Receptores Inmunológicos/inmunologíaRESUMEN
We have investigated beta2-glycoprotein I (beta2GPI) binding to platelet-derived microparticles (PMP) and its effect on GPIIb/IIIa. PMP were isolated from washed human platelets after stimulation with A23187, and analyzed by surface plasmon resonance spectroscopy. Beta2GPI as well as activated protein C (APC) or annexin V bound to PMP-coated sensorchips, demonstrating exposure of anionic phospholipids on immobilized PMP. Beta2GPI binding was impaired by calcium and occurred in a concentration-dependent manner with apparent k(on) = 2.6 x 10(4) M(-1) s(-1) and k(off) = 4.4 x 10(-3) s(-1), corresponding to a KD value of 1.7 x 10(-7) M. When analyzed by flow cytometry, the binding of certain mAbs specific for GPIIb and/or GPIIIa was reduced in the presence of beta2GPI but not of APC or annexin V, whereas the binding of anti-GPIb or anti-P-selectin mAbs, or of soluble fibrinogen remained unchanged. These results suggest a broad but specific influence of beta2GPI on GPIIb/IIIa immunoreactivity, and indicate that beta2GPI may act as a modulator of GPIIb/IIIa-dependent functions of PMP.
Asunto(s)
Plaquetas/ultraestructura , Glicoproteínas/metabolismo , Glicoproteínas/farmacología , Complejo GPIIb-IIIa de Glicoproteína Plaquetaria/efectos de los fármacos , Anticuerpos Monoclonales/metabolismo , Unión Competitiva , Plaquetas/efectos de los fármacos , Calcimicina/farmacología , Calcio/farmacología , Membrana Celular/química , Membrana Celular/ultraestructura , Fibrinógeno/metabolismo , Humanos , Complejo GPIIb-IIIa de Glicoproteína Plaquetaria/inmunología , Complejo GPIIb-IIIa de Glicoproteína Plaquetaria/metabolismo , Unión Proteica , Fracciones Subcelulares/química , Fracciones Subcelulares/metabolismo , Resonancia por Plasmón de Superficie , beta 2 Glicoproteína IRESUMEN
INTRODUCTION: The assay of endogenous erythroid colony formation (EEC), a characteristic of polycythemia vera and essential thrombocythemia, is not standardized. In this multicentric study, we tested four semisolid, serum-free, cytokine-free media based on either methylcellulose (M1, M2) or collagen (C1, C2) commercialized for the EEC assay. MATERIALS AND METHODS: Bone marrow mononuclear cells (BMMC) from 73 individuals (62 patients with either polycythemia vera (26), essential thrombocythemia (19), secondary polyglobuly (17) or chronic myeloid leukemia (2) and 11 healthy donors) were grown in parallel in the four media without, or with 0.01 U/ml erythropoietin (EPo). RESULTS: In all four media EEC formation was specific, as it was not observed in cultures of patients with secondary polyglobuly or chronic myeloid leukemia, nor of healthy donors. Analysis of fresh or MGG-stained collagen gel cultures allowed detection of EEC formation significantly more frequently than methylcellulose-based media; addition of 0.01 U/ml of EPo had little or no effect on EEC formation. Collagen-based medium C1 gave better results than the other media tested: the 'C1' EEC assay was positive for 68.2% of polycythemia vera cultures with significantly higher median EEC numbers (6.5/10(5) BMMC for patients with one major criteria of polycythemia vera and 19 and 21/10(5) BMMC for patients with two or three major criteria, respectively). Medium C1 was also better for essential thrombocythemia cultures with 47.4% of positive results but with a low median EEC number (6.7/10(5) BMMC). When associated with the ELISA dosage of serum EPo, the 'C1' EEC assay allowed confirmation or elimination of the diagnosis of polycythemia vera for 91% (20/22) of polyglobulic patients. CONCLUSION: We propose that serum-free collagen-based culture systems be considered to standardize the EEC assay, now part of the new criteria of polycythemia vera.
Asunto(s)
Ensayo de Unidades Formadoras de Colonias/normas , Medio de Cultivo Libre de Suero , Citocinas/farmacología , Células Precursoras Eritroides/patología , Policitemia Vera/patología , Trombocitemia Esencial/patología , Células de la Médula Ósea/patología , Estudios de Casos y Controles , Técnicas de Cultivo de Célula , División Celular/efectos de los fármacos , Colágeno , Ensayo de Unidades Formadoras de Colonias/métodos , Humanos , Metilcelulosa , Policitemia Vera/diagnóstico , Trombocitemia Esencial/diagnósticoRESUMEN
We describe two brothers who suffered from hyper-IgM syndrome (HIGM1) with similar clinical features: recurrent infections, especially cryptosporidium gastroenteritis with cholangitis. Their activated T cells did not express CD40L. Nucleotide sequencing revealed a mutation in both boys with respect to intron 4 and exon 5 boundaries of the CD40L gene in Xq26. They underwent successful bone marrow transplantation (BMT) from HLA-geno-identical siblings. The Cryptosporidium infection and cholangitis resolved thereafter. At 6 months after BMT, expression of CD40L on activated T lymphocytes was normal. After 1 year, both boys are well, and immune reconstitution has improved. Based on these two successful experiences, BMT with a genoidentical sibling seems a reasonable therapeutic approach for HIGM1, if Cryptosporidium infection occurs.
Asunto(s)
Trasplante de Médula Ósea , Criptosporidiosis/etiología , Cryptosporidium parvum , Inmunoglobulina M , Síndromes de Inmunodeficiencia/terapia , Animales , Ligando de CD40/análisis , Ligando de CD40/genética , Niño , Colangitis Esclerosante/parasitología , Criptosporidiosis/patología , Análisis Mutacional de ADN , Gastroenteritis/parasitología , Enfermedades Genéticas Ligadas al Cromosoma X/terapia , Humanos , Síndromes de Inmunodeficiencia/complicaciones , Masculino , Mutación , Hermanos , Linfocitos T/inmunología , Trasplante Homólogo , Trasplante Isogénico , Resultado del TratamientoRESUMEN
To investigate the function of the main adhesion receptors (CD62L, CD49d, CD49e, CD11b and CD18) on CD34+ cells during homing, their expression was quantified by flow cytometry using calibration beads. CD34+ cells were isolated from bone-marrow (BM), cord blood (CB) or peripheral blood (PB) from patients with myeloma. As this process might mimic the mature leukocyte migration, we also observed the effect of exposing endothelial cells to shear stress (7 dyn/cm(2)) on the adhesion of CB CD34+ cells. The proportion of CD34+/CD62L+ cells was greater in PB than in BM (p<0.05). Likewise, we found a significantly greater expression of CD62L receptor on PB cells compared to BM cells (p<0.05) and on BM cells compared to CB cells (p<0.05). The proportions of CD34+/CD49d+ cells and CD34+/CD49e+ cells were significantly higher in the BM and CB than in PB. However, no significant difference in CD49d or CD49e antigen densities was observed. The beta_2 integrins (CD11b and CD18) receptors are also implicated in CD34+ cells homing to BM. No significant variation in CD34+/CD11b+ and CD34+/CD18+ cells frequency was noted. However quantitative analysis revealed that CD18 was more strongly expressed on BM cells than on PB and CB cells. The adhesion assay showed that fluid flow may favour a firm adhesion of CB CD34+ cells to endothelial cells whereas static conditions just allowed CD34+ cells sedimentation. In conclusion, quantitative expression of the main receptors on CD34+ cells indicates that the three main sources of CD34+ cells currently used for transplantation have neither the same phenotype nor the same number of antigenic sites for a receptor. So, we hypothesize that migrational capacity of these cells might be different. Moreover, it seems that shear stress could favor adhesion of CD34+ cells to endothelial cells.
Asunto(s)
Antígenos CD34/metabolismo , Moléculas de Adhesión Celular/metabolismo , Endotelio Vascular/citología , Células Madre Hematopoyéticas/citología , Células de la Médula Ósea/metabolismo , Adhesión Celular/fisiología , Movimiento Celular/fisiología , Sangre Fetal/metabolismo , Citometría de Flujo , Trasplante de Células Madre Hematopoyéticas , Células Madre Hematopoyéticas/metabolismo , Humanos , Recién Nacido , Estrés MecánicoRESUMEN
The aim of this work was to quantify by flow cytometry the main adhesion receptors on CD34+ cells. These cells were isolated from bone marrow (BM) or mobilized peripheral blood (PB). The proportions of CD34+/CD49d+ and CD34+/CD49e+ are weaker on PB cells, without quantitative expression variation. This phenotypic variation may induce CD34+ cells exist from BM into circulation, promoting the mobilization. The homing to the BM implicate the CD62L receptor, which expression was found more frequently and stronger on PB cells than on BM. The CD11b, CD18 and CD54 receptors are implicated in CD34+ cells adhesion to BM micro-environment. No significant variation in CD34+/CD11b+ and CD34+/CD18+ cells frequency was noted. Moreover, CD54 receptor was more frequently expressed on PB cells. Quantitative analysis revealed that CD18 was more strongly expressed on BM than on PB cells. This quantitative variation could promote progenitor adhesion by interacting with stromal cells. Finally, quantitative expression of the main receptors on CD34+ cells provides an original option for studying CD34+ cells during the mobilization, the homing or the adhesion to BM micro-environment.
Asunto(s)
Adhesión Celular/fisiología , Regulación de la Expresión Génica , Células Madre Hematopoyéticas/metabolismo , Integrinas/biosíntesis , Molécula 1 de Adhesión Intercelular/biosíntesis , Selectina L/biosíntesis , Antígenos CD/análisis , Antineoplásicos/farmacología , Células Sanguíneas/metabolismo , Células de la Médula Ósea/metabolismo , Antígenos CD18/análisis , Filgrastim , Supervivencia de Injerto , Factor Estimulante de Colonias de Granulocitos/farmacología , Movilización de Célula Madre Hematopoyética , Trasplante de Células Madre Hematopoyéticas , Humanos , Inmunofenotipificación , Integrina alfa4 , Integrina alfa4beta1 , Integrina alfa5 , Integrinas/genética , Molécula 1 de Adhesión Intercelular/análisis , Molécula 1 de Adhesión Intercelular/genética , Selectina L/genética , Antígeno de Macrófago-1/análisis , Antígeno de Macrófago-1/biosíntesis , Antígeno de Macrófago-1/genética , Modelos Biológicos , Mieloma Múltiple/terapia , Especificidad de Órganos , Receptores de Fibronectina/biosíntesis , Receptores de Fibronectina/genética , Receptores Mensajeros de Linfocitos/biosíntesis , Receptores Mensajeros de Linfocitos/genética , Proteínas Recombinantes , Reproducibilidad de los ResultadosRESUMEN
The adhesion of polymorphonuclear leukocytes (PMNs) on the vascular endothelium is a complex process that occurs during biological and pathological events and involves a large family of molecules. This phenomenom could be approached by a modelisation study of the adhesion of PMNs on a biological substrate, fibrinogen. Two different physiological conditions were tested such as the activated state of PMNs with a synthetic pro-inflammatory activator (N-Formyl-Methionyl-Leucyl-Phenylalanine, FMLP). The activated state of PMNs was both quantified by flow cytometry and controlled by fluorescence microscopy. The results suggest that quiescent PMNs deposit in accordance with the ballistic deposition model. The preliminary results obtained with FMLP-stimulated PMNs show a different deposit process compared to quiescent PMNs but do not allow to determine exactly a deposition model.
Asunto(s)
Fibrinógeno/metabolismo , Leucocitos/fisiología , Modelos Biológicos , Molécula de Adhesión Celular del Leucocito Activado/análisis , Adhesión Celular/efectos de los fármacos , Adhesión Celular/fisiología , Fibrinógeno/farmacología , Citometría de Flujo , Humanos , Recuento de Leucocitos/efectos de los fármacos , Leucocitos/efectos de los fármacos , Microscopía Fluorescente , N-Formilmetionina Leucil-Fenilalanina/farmacología , Propiedades de Superficie/efectos de los fármacosRESUMEN
UNLABELLED: Polymorphonuclear neutrophil (PMN) adherence receptors expression varies with leukocyte activation state. Their quantification need accurate and inter-laboratories reproducible methods, without artefactual activation. OBJECTIVE: The aim of this study was to study the influence of cell preparation on PMN adherence receptors expression. MATERIALS AND METHODS: It was proposed to quantify, using immunolabeling standard (QIFIKIT(R), Dako), surface expression of the main adherence receptors (L-selectin and B(2) integrins), from different preparations of PMN: total blood collected with EDTA, isolated PMN by density gradient Polymorphprep(TM) 1,113 (Nycomed Pharma) and formaldehyde fixed PMN. RESULTS: A decrease of all receptors was noted after isolation and fixation of PMN, in comparison with whole blood PMN analysis. These results differed from data previously reported since, in these studies, activated phenotypes (increased of B(2) integrins) were observed after isolation and fixation methods. CONCLUSION: The present study provides strong evidence that pre-analytical conditions are sources of biological variations and thus extreme care must be taken in the interpretation of results. It underlines the interest of consensual practices for these pre-analytic and analytic parameters in order to compare results in multicenter and longitudinal studies.
Asunto(s)
Antígenos CD18/sangre , Selectina L/sangre , Neutrófilos/fisiología , Adhesión Celular , Separación Celular/métodos , Humanos , Activación Neutrófila , Neutrófilos/citología , Fijación del Tejido/métodosRESUMEN
The adhesion of polymorphonuclear leukocytes (PMNs) on the vascular endothelium is a complex process that occurs during different biological and pathological events and involves numerous molecules. The adhesion cascade is induced after PMN stimulation by various molecular or cellular signals. Fibrinogen is one of the substrates for CD11b/CD18 B2-integrins expressed at the PMN surface; fibrinogen-neutrophil binding is induced by inflammatory reactions. In order to understand this process, we have carried out studies on the basis of preliminary experiments on red blood cells and synthetic particles. The modelization of quiescent PMNs adhesion on a fibrinogen substrate was investigated with a sedimentation cell chamber. Two different physiological conditions were tested: the activated state of PMN by a synthetic pro-inflammatory activator (FMLP). The activated state of PMNs was both quantified by flow cytometry and controlled by fluorescence microscopy. The results suggest that quiescent neutrophils deposit in accordance with the ballistic deposition model. This random adsorption model differs from random sequential adsorption (RSA) in that the cells arriving at the surface are able to roll along cells previously adsorbed introducing the notion of gravitational attraction of cells. The preliminary results obtained with stimulated PMN do not allow to choose between one of this two deposition models. Nevertheless, the qualitative and quantitative effects of FMLP on neutrophils were demonstrated by modifications of adhesion molecules expression.
Asunto(s)
Adhesión Celular , Fibrinógeno/fisiología , Leucocitos/fisiología , Antígenos CD/fisiología , Antígenos CD18/fisiología , Hemoglobinas/fisiología , Humanos , Antígeno de Macrófago-1/fisiología , Modelos BiológicosRESUMEN
Leukoagglutination is a rare EDTA-dependent phenomenon resulting in a spurious minoration of the leukocyte count performed using automated analyzers. We described seven cases. The leukocyte agglutination was detected by unstable WBC count, abnormal WBC histograms and presence of clusters of polymorphonuclears on the smear. PMN aggregates of 3 to 10 cells or bigger were observed. Discrepancies between the erroneous automated WBC count and the real count were moderate in most cases. Leukoagglutination was related to lymphoproliferative disorders, infections, alcoholic liver diseases, auto-immune diseases. Inflammatory context seemed to be requested. For few patients, the artefact occurred regardless of the type of anticoagulants (lithium heparin, buffered sodium citrate) and warming at 37 C did not always increase the WBC. Dilution in Unopette chambers was required. We confirmed that leukoagglutination of PMN was an in vitro artefact EDTA and/or temperature mediated.